INDO US BIOTECH LTD Financial Ratios
INDOUS · Fast Moving Consumer Goods · Current price ₹78.97
P/E ratio
12.1x
P/B ratio
1.8x
ROE
14.1%
ROCE
14.0%
Debt / Equity
0.40
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 12.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 14.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.40 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with INDO US BIOTECH LTD's latest numbers.
INDO US BIOTECH LTD profitability
INDO US BIOTECH LTD generates a return on equity of 14.1% and a return on capital employed of 14.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.40 and a P/E of 12.1x, INDO US BIOTECH LTD is conservatively financed. Our overall business-quality score for the company is 5.4 / 10.
Understand the ratios
More on INDO US BIOTECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.